Greg Blotnick – CFA/NYSSA Membership, LinkedIn and Facebook

Greg Blotnick – Nine Baby Boomer Stocks To Buy

HCP, Inc.., a REIT with a 6.4% dividend yield. HCP has 1,200 properties specializing in senior housing, life science and medical offices, with a diversified mix of independent and assisted living. Shareholders have enjoyed a compound annual return of 14.9% since their 1985 IPO, and HCP has increased their dividend for 31 consecutive years. Healthcare expenditures are set to increase with the “graying of America” and HCP is well-positioned to capture this secular growth with their unique, diversified real estate portfolio.

Home Depot (HD) – Boomers entering retirement will spend their free time fixing up their homes, or spending money on second homes to renovate. The stock yields 2.25%, ahead of the S&P 500, and recently hiked their dividend by 17%. Home Depot is the 2nd-best performing stock of the last 30 years, with a cumulative return of nearly 68,000% or ~24% annualized. Revenues should hit $100 billion in 2018 and the industry enjoys long-term secular tailwinds in an aging housing stock and new household formation.

Amazon, Inc. (AMZN) – As boomers age, their preference will shift towards the convenience of ordering online rather than driving to the store. Bezos’ e-commerce monster now captures over 50 cents of each incremental dollar spent online and twenty years of reinvestment are finally showing up in the form of margin expansion and triple-digit growth in free cash flow. Other growth drivers include Prime Video and the firm’s recent entrance into logistics.

Blog Stats

Goodreads

Wells Fargo & Co's board is in talks with Harvey Schwartz, the former president and co-chief operating officer of Goldman Sachs Group Inc, to take over as the bank's chief executive, the New York Post reported on Thursday, citing people briefed on the discussion.

Indonesian investigators described the panic of pilots grappling with airspeed and altitude problems in the last moments of their doomed Lion Air flight, as comparisons mounted to a disaster in Ethiopia and authorities queued up to question Boeing.

Reuters - Biogen and partner Eisai Co Ltd are ending two late-stage trials for the experimental Alzheimer's drug aducanumab, in a setback to efforts to find treatments for the disease and for Biogen's stock, which lost more than $17 billion of its value on Thursday.

A political rift has emerged in Berlin over whether Germany should put its financial muscle behind a merger of Deutsche Bank and Commerzbank, politicians and officials said, complicating a bid to create Europe’s third-largest bank and fund it.

Federal Reserve policymakers see a U.S. economy that is rapidly losing momentum. They predict inflation will miss their 2 percent target for yet another year, despite rising wages, and they expect unemployment to increase.